BDBM267783 4-(4-amino-1-{(3R)-1-[(3-methyloxetan-3-yl)carbonyl]piperidin-3-yl}-1H-pyrazolo[4,3-c]pyridin-3-yl)-N-(4-methoxypyridin-2-yl)benzamide::US9718828, Example, 389

SMILES CC1(COC1)C(=O)N1CCC[C@H](C1)n1cc(-c2ccc(cc2)C(=O)Nc2cc(ccn2)C(F)(F)F)c2c(N)ncnc12

InChI Key InChIKey=FPLZDJUZRCBQAF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 267783   

TargetTyrosine-protein kinase BTK(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267783(4-(4-amino-1-{(3R)-1-[(3-methyloxetan-3-yl)carbony...)
Affinity DataIC50: 10nMpH: 7.2Assay Description:BTK enzymatic activity was determined in an IMAP-FP assay (Immobilized Metal ion Affinity-based fluorescence Polarization; Molecular Devices). Using ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2018
Entry Details
US Patent